86 related articles for article (PubMed ID: 17108689)
1. Ca channel currents inhibited by serum from select patients with Guillain-Barré syndrome.
Nakatani Y; Kawakami K; Nagaoka T; Utsunomiya I; Tanaka K; Yoshino H; Miyatake T; Hoshi K; Taguchi K
Eur Neurol; 2007; 57(1):11-8. PubMed ID: 17108689
[TBL] [Abstract][Full Text] [Related]
2. Cav2.1 voltage-dependent Ca2+ channel current is inhibited by serum from select patients with Guillain-Barré syndrome.
Nakatani Y; Hotta S; Utsunomiya I; Tanaka K; Hoshi K; Ariga T; Yu RK; Miyatake T; Taguchi K
Neurochem Res; 2009 Jan; 34(1):149-57. PubMed ID: 18478327
[TBL] [Abstract][Full Text] [Related]
3. IgG from patients with Guillain-Barré syndrome interact with nicotinic acetylcholine receptor channels.
Krampfl K; Mohammadi B; Buchwald B; Jahn K; Dengler R; Toyka KV; Bufler J
Muscle Nerve; 2003 Apr; 27(4):435-41. PubMed ID: 12661044
[TBL] [Abstract][Full Text] [Related]
4. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.
Taguchi K; Ren J; Utsunomiya I; Aoyagi H; Fujita N; Ariga T; Miyatake T; Yoshino H
J Neurol Sci; 2004 Oct; 225(1-2):91-8. PubMed ID: 15465091
[TBL] [Abstract][Full Text] [Related]
5. IgG anti-GalNAc-GD1a antibody inhibits the voltage-dependent calcium channel currents in PC12 pheochromocytoma cells.
Nakatani Y; Nagaoka T; Hotta S; Utsunomiya I; Yoshino H; Miyatake T; Hoshi K; Taguchi K
Exp Neurol; 2007 Mar; 204(1):380-6. PubMed ID: 17234185
[TBL] [Abstract][Full Text] [Related]
6. IgM anti-GQ1b monoclonal antibody inhibits voltage-dependent calcium current in cerebellar granule cells.
Nakatani Y; Murata M; Shibata K; Nagaoka T; Utsunomiya I; Usuki S; Miyatake T; Hoshi K; Taguchi K
Exp Neurol; 2009 Sep; 219(1):74-80. PubMed ID: 19306874
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
Nachamkin I; Arzarte Barbosa P; Ung H; Lobato C; Gonzalez Rivera A; Rodriguez P; Garcia Briseno A; Cordero LM; Garcia Perea L; Perez JC; Ribera M; Aldama PC; Guitérrez GD; Sarnat LF; García MR; Veitch J; Fitzgerald C; Cornblath DR; Rodriguez Pinto M; Griffin JW; Willison HJ; Asbury AK; McKhann GM
Neurology; 2007 Oct; 69(17):1665-71. PubMed ID: 17898327
[TBL] [Abstract][Full Text] [Related]
8. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.
Buchwald B; Toyka KV; Zielasek J; Weishaupt A; Schweiger S; Dudel J
Ann Neurol; 1998 Dec; 44(6):913-22. PubMed ID: 9851436
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
Buchwald B; Ahangari R; Weishaupt A; Toyka KV
Ann Neurol; 2002 Jun; 51(6):673-80. PubMed ID: 12112071
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological subtypes and prognosis of childhood Guillain-Barré syndrome in Japan.
Nagasawa K; Kuwabara S; Misawa S; Fujii K; Tanabe Y; Yuki N; Hattori T; Kohno Y
Muscle Nerve; 2006 Jun; 33(6):766-70. PubMed ID: 16506153
[TBL] [Abstract][Full Text] [Related]
12. The refractory period of transmission is impaired in axonal Guillain-Barré syndrome.
Kuwabara S; Bostock H; Ogawara K; Sung JY; Kanai K; Mori M; Hattori T; Burke D
Muscle Nerve; 2003 Dec; 28(6):683-9. PubMed ID: 14639581
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody-mediated dysfunction of sympathetic neurons in guillain-barre syndrome.
Lehmann HC; Jangouk P; Kierysch EK; Meyer zu Hörste G; Hartung HP; Kieseier BC
Arch Neurol; 2010 Feb; 67(2):203-10. PubMed ID: 20142528
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous muscle action potentials are blocked by N-type and P/Q-calcium channels blockers in the rat spinal cord-muscle co-culture system.
Taguchi K; Shiina M; Shibata K; Utsunomiya I; Miyatake T
Brain Res; 2005 Feb; 1034(1-2):62-70. PubMed ID: 15713260
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory infiltrates in the spinal cord of patients with Guillain-Barré syndrome.
Müller HD; Beckmann A; Schröder JM
Acta Neuropathol; 2003 Dec; 106(6):509-17. PubMed ID: 13680278
[TBL] [Abstract][Full Text] [Related]
16. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
17. AIDP and CIDP having specific antibodies to the carbohydrate epitope (-NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glc-) of gangliosides.
Usuki S; Sanchez J; Ariga T; Utsunomiya I; Taguchi K; Rivner MH; Yu RK
J Neurol Sci; 2005 May; 232(1-2):37-44. PubMed ID: 15850580
[TBL] [Abstract][Full Text] [Related]
18. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.
Wang XK; Zhang HL; Meng FH; Chang M; Wang YZ; Jin T; Mix E; Zhu J
Neurol Sci; 2013 May; 34(5):655-61. PubMed ID: 22526766
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of Guillain-Barré syndrome in a tropical country: a Brazilian experience.
Dourado ME; Félix RH; da Silva WK; Queiroz JW; Jeronimo SM
Acta Neurol Scand; 2012 Jan; 125(1):47-53. PubMed ID: 21428966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
